The global apheresis equipment market size reached US$ 2.6 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 5.4 Billion by 2032, exhibiting a growth rate (CAGR) of 8.46% during 2023-2032.
Apheresis equipment is used to remove specific constituents from the blood, such as the cells, plasma, platelets or leukocytes, using either centrifugal or membrane filtration methods. The remaining blood components are then reintroduced into the bloodstream of the donor or patient. It finds application in blood banks and the treatment of various medical conditions. In recent years, the introduction of modern apheresis equipment has led to the development of advanced features, such as auto elutriation and fluid flow dynamics, and has enabled the collection of platelets or red blood cells (RBCs) concentrates.
Due to the spread of the coronavirus disease (COVID-19) and lack of an effective vaccine or treatment, convalescent plasma therapy is emerging as a measure for treating critically ill patients. Apheresis equipment is utilized in this therapy to collect convalescent plasma (CP) from fully recovered patients and transfuse it to active patients as a source of antibodies. Besides this, the growing prevalence of chronic diseases and neurological disorders, along with the rising number of blood donors, is also contributing to the market growth.
Moreover, favorable reimbursement policies, coupled with improving healthcare infrastructure, are also driving the sales of apheresis equipment around the world. Other factors, such as the introduction of advanced variants with automated interface systems, screen navigation and graphical user interface displays, along with the increasing investments in research and development (R&D) activities, are expected to create a positive outlook for the market in the coming years.
Apheresis equipment is used to remove specific constituents from the blood, such as the cells, plasma, platelets or leukocytes, using either centrifugal or membrane filtration methods. The remaining blood components are then reintroduced into the bloodstream of the donor or patient. It finds application in blood banks and the treatment of various medical conditions. In recent years, the introduction of modern apheresis equipment has led to the development of advanced features, such as auto elutriation and fluid flow dynamics, and has enabled the collection of platelets or red blood cells (RBCs) concentrates.
Due to the spread of the coronavirus disease (COVID-19) and lack of an effective vaccine or treatment, convalescent plasma therapy is emerging as a measure for treating critically ill patients. Apheresis equipment is utilized in this therapy to collect convalescent plasma (CP) from fully recovered patients and transfuse it to active patients as a source of antibodies. Besides this, the growing prevalence of chronic diseases and neurological disorders, along with the rising number of blood donors, is also contributing to the market growth.
Moreover, favorable reimbursement policies, coupled with improving healthcare infrastructure, are also driving the sales of apheresis equipment around the world. Other factors, such as the introduction of advanced variants with automated interface systems, screen navigation and graphical user interface displays, along with the increasing investments in research and development (R&D) activities, are expected to create a positive outlook for the market in the coming years.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global apheresis equipment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application, procedure, technology and end user.Breakup by Product:
- Disposable Apheresis Kits
- Apheresis Machine
Breakup by Application:
- Blood Collection
- Treatment
- Neurology
- Hematology
- Renal Diseases
- Others
Breakup by Procedure:
- Plasmapherasis
- Plateletpherasis
- Erythrocytapheresis
- Leukapheresis
- Photopheresis
- Others
Breakup by Technology:
- Membrane Filtration
- Centrifugation
Breakup by End User:
- Blood Collection Centers
- Hospitals and Clinics
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Asahi Kasei Corporation, B. Braun Melsungen Aktiengesellschaft, Baxter International Inc., Fresenius Kabi Aktiengesellschaft (Fresenius SE & Co. KGaA), Haemonetics Corporation, Hemacare Corporation (Charles River Laboratories Inc.), Kaneka Corporation, Kawasumi Laboratories Inc., Medica SpA, Nikkiso Co Ltd. and Terumo BCT Inc. (Terumo Corporation).Key Questions Answered in This Report:
- How has the global apheresis equipment market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global apheresis equipment market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the procedure?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global apheresis equipment market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface3 Executive Summary13 Value Chain Analysis15 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Apheresis Equipment Market
6 Market Breakup by Product
7 Market Breakup by Application
8 Market Breakup by Procedure
9 Market Breakup by Technology
10 Market Breakup by End User
11 Market Breakup by Region
12 SWOT Analysis
14 Porters Five Forces Analysis
16 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Asahi Kasei Corporation
- B. Braun Melsungen Aktiengesellschaft
- Baxter International Inc.
- Fresenius Kabi Aktiengesellschaft (Fresenius SE & Co. KGaA)
- Haemonetics Corporation
- Hemacare Corporation (Charles River Laboratories Inc.)
- Kaneka Corporation
- Kawasumi Laboratories Inc.
- Medica SpA
- Nikkiso Co Ltd.
- Terumo BCT Inc. (Terumo Corporation)
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 144 |
Published | August 2024 |
Forecast Period | 2023 - 2032 |
Estimated Market Value ( USD | $ 2.6 Billion |
Forecasted Market Value ( USD | $ 5.4 Billion |
Compound Annual Growth Rate | 8.5% |
Regions Covered | Global |
No. of Companies Mentioned | 11 |